Seroprevalence of herpes simplex virus type 1 and type 2 and coinfection with HIV and syphilis: The first national seroprevalence survey in Saudi Arabia

Sexually Transmitted Diseases

Volumn 42, Issue 9, 2015, Pages 526-532

  Memish, Ziad A ^a,b   Almasri, Malak ^b   Chentoufi, Aziz A ^c   Al Tawfiq, Jaffar A ^d,e   Al Shangiti, Ali M ^b   Al Kabbani, Kenan M ^b   Otaibi, Badriah ^b   Assirri, Abdullah ^b   Yezli, Saber ^b  

^a ALFAISAL UNIVERSITY   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c KING FAHAD MEDICAL CITY   (Saudi Arabia)

^d DHAHRAN HEALTH CENTER   (Saudi Arabia)

^e INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; RURAL AREA; SAUDI ARABIA; SEROPREVALENCE; SEX RATIO; SEXUAL BEHAVIOR; SYPHILIS; TREPONEMA PALLIDUM; URBAN AREA; ADOLESCENT; AGED; BLOOD; COINFECTION; CROSS-SECTIONAL STUDY; HERPES SIMPLEX; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES; SURVEYS AND QUESTIONNAIRES; SYPHILIS; TREPONEMA PALLIDUM; YOUNG ADULT;

EID: 84939783576     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000336     Document Type: Article

References (29)

1. Fatahzadeh M, Schwartz RA,. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol 2007; 57: 737-763
2. Azwa A, Barton SE,. Aspects of herpes simplex virus: A clinical review. J Fam Plann Reprod Health Care 2009; 35: 237-242
3. Anzivino E, Fioriti D, Mischitelli M, Herpes simplex virus infection in pregnancy and in neonate: Status of art of epidemiology, diagnosis, therapy and prevention. Virol J 2009; 6: 40
4. Chentoufi AA, Dervillez X, Rubbo PA, Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Curr Trends Immunol 2012; 13: 51-68
5. Freeman EE, Weiss HA, Glynn JR, Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-Analysis of longitudinal studies. AIDS 2006; 20: 73-83
6. Wald A, Link K,. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-Analysis. J Infect Dis 2002; 185: 45-52
7. Looker KJ, Garnett GP, Schmid GP,. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008; 86: 805-812
8. Smith JS, Robinson NJ,. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002; 186 (suppl 1): S3-S28
9. Looker KJ, Magaret AS, Turner KM, Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One 2015; 10: e114989
10. Madani TA,. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis 2006; 6: 3
11. Abu-Raddad LJ, Schiffer JT, Ashley R, HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics 2010; 2: 173-182
12. Wellinghausen N, Dietenberger H,. Evaluation of two automated chemiluminescence immunoassays, the LIAISON Treponema Screen and the ARCHITECT Syphilis TP, and the Treponema pallidum particle agglutination test for laboratory diagnosis of syphilis. Clin Chem Lab Med 2011; 49: 1375-1377
13. Chavez P, Wesolowski L, Patel P, Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol 2011; 52 (suppl 1): S51-S55
14. Fageeh WM,. Sexually transmitted infections among patients with herpes simplex virus at King Abdulaziz University Hospital. BMC Res Notes 2013; 6: 301
15. Xu F, Sternberg MR, Kottiri BJ, Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296: 964-973
16. Obeid OE,. Prevalence of herpes simplex virus types 1 and 2 and associated sociodemographic variables in pregnant women attending King Fahd Hospital of the university. J Family Community Med 2007; 14: 3-7
17. Alzahrani AJ, Obeid OE, Almulhim AA,. Analysis of herpes simplex 1 and 2 IgG and IgM antibodies in pregnant women and their neonates. Saudi J Obstet Gynaecol 2005; 5: 53
18. Hasan ASH, Al-Duliami AA, Hwaid AH, Seroprevalence of anti-herpes simplex virus type 2 IgG, IgM antibodies among pregrant women in Diyala province. Diyala J Med 2013; 5: 36-43
19. Mugo N, Dadabhai SS, Bunnell R, Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya. Sex Transm Dis 2011; 38: 1059-1066
20. Garnett GP, Dubin G, Slaoui M, The potential epidemiological impact of a genital herpes vaccine for women. Sex Transm Infect 2004; 80: 24-29
21. Al-Sibiani SA,. Prenatal screening syphilis: Is universal screening necessary in Saudi Arabia. JKAU: Med Sci 2008; 15: 41-48
22. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Epidemiology of the human immunodeficiency virus in Saudi Arabia; 18-year surveillance results and prevention from an Islamic perspective. BMC Infect Dis 2004; 4: 25
23. Tobian AA, Quinn TC,. Herpes simplex virus type 2 and syphilis infections with HIV: An evolving synergy in transmission and prevention. Curr Opin HIV AIDS 2009; 4: 294-299
24. Caldeira TD, Goncalves CV, Oliveira GR, Prevalence of herpes simplex virus type 2 and risk factors associated with this infection in women in southern Brazil. Rev Inst Med Trop Sao Paulo 2013; 55: 315-321
25. Fukuchi E, Sawaya GF, Chirenje M, Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis 2009; 36: 305-311
26. Chopra S, Devi P, Devi B,. Herpes simplex virus 2: A boon to develop other sexually transmitted infections. J Indian Med Assoc 2013; 111: 236-238
27. Centers for Disease Control and Prevention (CDC). Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2010; 59: 456-459
28. Bradley H, Markowitz LE, Gibson T, Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999-2010. J Infect Dis 2014; 209: 325-333
29. Langenberg AG, Corey L, Ashley RL, A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432-1438